The Latest Breaking News from Recession

Amid the banking turmoil and the Fed’s latest quarter-point rate hike, the odds of a recession are back on the rise. Hence, it could be wise to invest in no-brainer stocks Taiwan Semiconductor Manufacturing (TSM), Novo Nordisk (NVO), and Merck & Co. (MRK) now. Read more….

Federal Reserve policymakers have targeted a “soft landing” for the U.S. economy since beginning their effort a year ago to tame runaway inflation by hiking interest rates. That is, they believed they could do so without sending the U.S. into recession.

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately. Amid this backdrop, investors could consider buying fundamentally sound, large-cap stocks Taiwan Semiconductor (TSM), Johnson & Johnson (JNJ), and Merck (MRK),…

The bank failures and the Fed’s monetary tightening have increased the risk of a recession later this year. This is expected to keep the stock market under pressure. Amid this uncertainty, it could be wise to buy and hold fundamentally strong stocks Oracle (ORCL), CVS Health (CVS), and Humana (HUM)…

The announcement came as the bank announced it would raise interest rates to 4.25%

The economy has been in turbulence for many months, and a combination of global conditions and domestic policies will have extended these conditions well into 2023 and likely beyond. Although it’s looking less likely the UK will suffer a technical recession this year, the economy is still set to contract.…

Recent turmoil in the financial sector, renewed recession worries, and the Fed’s continued rate hikes paint an unfavorable picture for the stock market and economy. Amid this, long-term investors could opt for fundamentally sound stocks AstraZeneca (AZN), Cisco Systems (CSCO), and Ambev (ABEV) to withstand ongoing macroeconomic headwinds. Read more….

Coupled with macroeconomic headwinds, the sudden regional banking failures have marred investor sentiments. Moreover, amid anticipations of a recession, the existing market volatilities are not likely to subside anytime soon. Given this backdrop, we think the strong growth prospects of Gilead Sciences (GILD), Teva Pharmaceutical (TEVA), and MacroGenics (MGNX) make…

The banking crisis and the Fed’s determination to cool inflation with higher interest rate hikes are likely to tip the economy into a recession. Amid this backdrop, it could be wise for investors to focus on their long-term portfolios and buy fundamentally strong stocks Broadcom (AVGO), Coca-Cola (KO), and Casey’s…

The recent banking turmoil caused by high-profile bank failures, renewed recession fears, and uncertainty over the Fed’s next move have significantly affected investor sentiment. Amid an uncertain market backdrop, it could be wise to buy and hold fundamentally sound, dividend-paying stocks Oracle Corporation (ORCL), CVS Health (CVS), and Humana (HUM)…

Do not let this 2 day rally for the stock market (SPY) fool you. Consider it a temporary relief rally with things lining up for the next leg lower. At the heart of that is the negative consequences that ALWAYS comes with Fed rate hikes. This time is no different…